American Journal of Neuroradiology 24:1348-1354, August 2003
© 2003 American Society of Neuroradiology
BRAIN
Frequency of Subclinical Lacunar Infarcts in Ischemic Leukoaraiosis and Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
a Division of Clinical Neuroscience, St. Georges Hospital Medical School, London, England
b Department of Neuroradiology, St. Georges and Atkinson Morleys Hospitals, London, England
Address reprint requests to Professor Hugh S. Markus, Division of Clinical Neuroscience, St. Georges Hospital Medical School, Cranmer Terrace, London SW17 0RE, England
BACKGROUND AND PURPOSE: Small vessel cerebrovascular disease is an important cause of vascular cognitive impairment. It is usually sporadic but also occurs secondary to the genetic disorder cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Recurrent lacunar stroke is a characteristic feature, although symptomatic events are relatively rare, making large numbers necessary for evaluation of potential therapies. Diffusion-weighted imaging is sensitive to acute ischemic lesions and differentiates them from chronic infarcts. Detection of asymptomatic lacunar infarcts with diffusion-weighted imaging is a potential surrogate marker for treatment trials. In this study, the frequency of asymptomatic new lesions in ischemic leukoaraiosis and CADASIL was determined as a step toward assessing the potential of this technique as a surrogate marker of disease activity.
METHODS: Fifty patients with sporadic small vessel disease and 19 patients with CADASIL underwent diffusion-weighted imaging. All had been asymptomatic for 3 months before imaging. Diffusion-weighted images were screened by two raters for new lesions; lesions were confirmed as recent by a visible reduction of diffusivity on the corresponding apparent diffusion coefficient maps.
RESULTS: Recent ischemic lesions were identified in four patients with sporadic small vessel disease (8.0%) and two patients with CADASIL (10.5%).
CONCLUSION: Asymptomatic new lesions are found in cases of sporadic small vessel disease and CADASIL. The frequency of new lesions suggests that this approach has a potential role as a surrogate marker in therapeutic trials that warrants further investigation.
This article has been cited by other articles:
![]() |
T.J. Huynh, B. Murphy, J.A. Pettersen, H. Tu, D.J. Sahlas, L. Zhang, S.P. Symons, S. Black, T.-Y. Lee, and R.I. Aviv CT Perfusion Quantification of Small-Vessel Ischemic Severity AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1831 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viswanathan, A. Gschwendtner, J. -P. Guichard, F. Buffon, R. Cumurciuc, M. O'Sullivan, M. Holtmannspotter, C. Pachai, M. -G. Bousser, M. Dichgans, et al. Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL Neurology, July 10, 2007; 69(2): 172 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viswanathan, J.-P. Guichard, A. Gschwendtner, F. Buffon, R. Cumurcuic, C. Boutron, E. Vicaut, M. Holtmannspotter, C. Pachai, M.-G. Bousser, et al. Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study Brain, September 1, 2006; 129(9): 2375 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kim, E. J. Choi, C. G. Choi, G. Kim, J. H. Choi, H. W. Yoo, and J. S. Kim Characteristics of CADASIL in Korea: A novel cysteine-sparing Notch3 mutation Neurology, May 23, 2006; 66(10): 1511 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Wardlaw What causes lacunar stroke? J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 617 - 619. [Full Text] [PDF] |
||||
![]() |
D Chowdhury, J M Wardlaw, and M S Dennis Are multiple acute small subcortical infarctions caused by embolic mechanisms? J. Neurol. Neurosurg. Psychiatry, October 1, 2004; 75(10): 1416 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Peters, J. Herzog, C. Opherk, and M. Dichgans A Two-Year Clinical Follow-Up Study in 80 CADASIL Subjects: Progression Patterns and Implications for Clinical Trials Stroke, July 1, 2004; 35(7): 1603 - 1608. [Abstract] [Full Text] [PDF] |
||||




